Aura Biosciences (AURA) said Thursday that it has priced an
underwritten public offering of shares, prefunded warrants and warrants to raise $75 million.
The offering includes about 11.7 million shares and accompanying warrants to buy some 2.9 million shares, Aura said. The combined price of each share and warrant is $4.90.
The company said it is also offering some investors prefunded warrants to purchase up to about 3.6 million shares, along with warrants to buy up to 892,858 shares.
Aura said it plans to use the net proceeds to help advance its clinical programs and for general corporate purposes. It expects to close the offering May 16.
Shares of Aura were up more than 7% in recent trading.
Price: 5.26, Change: +0.36, Percent Change: +7.35
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.